Detection of low level nilotinib or dasatinib resistant BCR-ABL mutations by mass spectrometry in CML patients who fail Imatinib is highly predivtive of their subsequent clonal expansion when treated with the drug for which their mutation confers resistance

Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/65158

Type:	Conference paper
Title:	Detection of low level nilotinib or dasatinib resistant BCR-ABL mutations by mass spectrometry in CML patients who fail Imatinib is highly predivtive of their subsequent clonal expansion when treated with the drug for which their mutation confers resistance
Author:	Parker, W. Ho, M. Lawrence, R. Irwin, D. Scott, H. Hughes, T. Branford, S.
Citation:	Proceedings of 2010 american society of hematology meeting, 2010
Publisher:	AMER SOC HEMATOLOGY
Issue Date:	2010
ISSN:	0006-4971
Conference Name:	American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)
Statement of Responsibility:	Wendy T Parker, Musei Ho, Rebecca M Lawrence, Darryl L Irwin, Hamish S Scott, Timothy Hughes and Susan Branford
Rights:	Copyright status unknown
Description (link):	http://ash.confex.com/ash/2010/webprogram/Paper29762.html
Appears in Collections:	Aurora harvest Medicine publications

Files in This Item:

There are no files associated with this item.

Show full item record

Adelaide Research & Scholarship